Top Startup Award Marks a Year of Milestones for Colorado's Leading Mental Health InnovatorWESTMINSTER, CO / ACCESSWIRE / ...

BC, CANS, announces the launch of its Medical Director services and Private Training programs for aesthetic injectors. With over a decade of industry experience, Megan Davies is setting a new standard ...

Boehringer Ingelheim has entered a partnership with the NCD Alliance, a network dedicated to shaping a world in which ...

First Generation ‘MicroPearls Pro™'and "MicroPearls ProX™" Will Support Largest Mushroom Ingredient CategoriesLAS VEGAS, NV / ACCESSWIRE / September 30, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer ...

SAN DIEGO, CA / ACCESSWIRE / September 30, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

Lumpectomy Patients Received VeraForm® Marker and APBI Therapy for Breast Cancer TreatmentSAN FRANCISCO, CA / ACCESSWIRE / September 30, 2024 / A recent study accepted by the American Society of ...

Business combination to form a best-in-class, transformative oral biologics company - Synergies between Tharimmune's clinical-stage assets and Intract's delivery platform to drive pipeline growth - ...

CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized ...

MiscellaneousMedacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy 30.09.2024 / 12:00 CET/CESTMEDIA RELEASEMedacta Hosts Inaugural Capital ...

LONDON, UNITED KINGDOM / ACCESSWIRE / September 30, 2024 / Genflow (LSE:GENF) is pleased to announce its half year results for the six-month period ended 30 June 2024.Chairman's StatementIt is with ...

Alec Ogletree, former NFL linebacker that in retirement has been investing in and helping build consumer centric companies serving people in need, has joined T2D.com, a company focused on making ...

Regulatory Approval/Market LaunchFormycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz) 30.09.2024 / 07:30 CET/CESTThe issuer is solely responsible for the content of ...